FibroGen FGEN 深 沪
已收盘 08-01 16:00:00 美东时间
6.89
-0.030
-0.43%
华盛通- 最 高7.03
- 今 开6.85
- 成交量 1.44万股
- 最 低 6.805
- 昨 收 6.92
- 总市值 2784.80万
- 52周最高 21.9375
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.50
- 委 比 -79.53%
- 总股本 404.18万
- 历史最高 1713.75
- 量 比 0.61
- 振 幅 3.25%
- 历史最低 4.50
- 每 手 1
- 风险率 0.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FibroGen Amends Financing Agreement with Morgan Stanley
FibroGen ( ($FGEN) ) has issued an announcement. On July 14, 2025, FibroGen ame...
07-15 05:29
FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank
FibroBiologics announced advancements in its cartilage repair program, confirming that its CYWC628 spheroids can be directly differentiated into chondrocytes. This breakthrough enables the company to use its existing master cell bank to develop CybroCell™, an investigational cell therapy for degenerative disc disease (DDD). The milestone supports regulatory filings for a planned Phase I clinical trial and highlights the scalability of its fibrobl...
07-09 12:30
FibroGen Enters New Agreement with HiFiBiO
The latest update is out from FibroGen ( ($FGEN) ). On June 12, 2025, FibroGen ...
06-14 04:42
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of RH (NYSE:RH) rose sharply in today's pre-market trading as the compan...
06-13 17:08
Adobe, RH And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading lower this morning on Friday, some of the stock...
06-13 11:39
FibroGen shares are trading lower after the company announced a 1-for-25 reverse stock split.
FibroGen shares are trading lower after the company announced a 1-for-25 revers...
06-13 04:03
FibroGen Announces 1-for-25 Reverse Stock Split
FibroGen, Inc. announced a 1-for-25 reverse stock split of its common stock, effective June 16, 2025. The split aims to increase the per-share price to meet Nasdaq's minimum bid requirement. The number of outstanding shares will reduce from approximately 101.1 million to 4.0 million. Shareholders will receive cash for any fractional shares. The stock will resume trading on June 17 under the same symbol "FGEN" with a new CUSIP number. FibroGen foc...
06-12 20:02
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors
FibroGen, Inc. announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025. Dr. Kauffman, a biotech industry veteran with over 30 years of experience, especially in oncology, brings extensive leadership and drug development expertise. His insights will support FibroGen's pipeline progress and clinical milestones. Dr. Kauffman currently serves as CEO of Nereid Therapeutics and holds various board roles in oth...
06-09 20:02
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Theriva Biologics (AMEX:TOVX) stock moved upwards by 47.4% to $0.72 du...
06-03 05:05
Foresight Environmental Infrastructure Updates Share Capital Structure
Foresight Environmental Infrastructure Limited GBP ( ($GB:FGEN) ) has issued an...
06-02 17:42
